Case number 1:22-cv-06225
Bausch Health Ireland Limited et al v. Taro Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 5, 2022 | 13 | AO 120 Form Patent - Case Terminated - Submitted (3) Docket Text: AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 8/5/2022 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF)..(nd) |
| Aug 3, 2022 | 12 | Notice of Voluntary Dismissal (2) Docket Text: NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice and without costs against the defendant(s) Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. Document filed by Bausch Health Ireland Limited, Bausch Health Americas, Inc., Bausch Health US, LLC. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers)...(Anand, Nitya) |
| Jul 25, 2022 | N/A | Case Opening Initial Assignment Notice (0) Docket Text: CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge John P. Cronan. Please download and review the Individual Practices of the assigned District Judge, located at https://nysd.uscourts.gov/judges/district-judges. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at https://nysd.uscourts.gov/rules/ecf-related-instructions..(pc) |
| Jul 25, 2022 | N/A | Case Designation (0) Docket Text: Magistrate Judge James L. Cott is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: https://nysd.uscourts.gov/sites/default/files/2018-06/AO-3.pdf. (pc) |
| Jul 25, 2022 | N/A | Case Designated ECF (0) Docket Text: Case Designated ECF. (pc) |
| Jul 25, 2022 | 8 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceuticals Inc...(pc) |
| Jul 25, 2022 | 9 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceuticals U.S.A., Inc...(pc) |
| Jul 25, 2022 | 10 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to Taro Pharmaceutical Industries Ltd...(pc) |
| Jul 25, 2022 | 11 | Mail Patent Form (case opening) (1) Docket Text: AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF)..(pc) |
| Jul 22, 2022 | 1 | Main Document (16) Docket Text: COMPLAINT against Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc., Taro Pharmaceuticals U.S.A., Inc.. (Filing Fee $ 402.00, Receipt Number ANYSDC-26449562)Document filed by Bausch Health Ireland Limited, Bausch Health Americas, Inc., Bausch Health US, LLC. (Attachments: # (1) Exhibit A: copy of '307 Patent, # (2) Exhibit B: copy of 502 Patent, # (3) Exhibit C: copy of 895 Patent, # (4) Exhibit D: copy of 787 Patent).(Anand, Nitya) |
| Jul 22, 2022 | 1 | Exhibit A: copy of '307 Patent (10) |
| Jul 22, 2022 | 1 | Exhibit B: copy of 502 Patent (9) |
| Jul 22, 2022 | 1 | Exhibit C: copy of 895 Patent (13) |
| Jul 22, 2022 | 1 | Exhibit D: copy of 787 Patent (14) |
| Jul 22, 2022 | 2 | Civil Cover Sheet (2) Docket Text: CIVIL COVER SHEET filed..(Anand, Nitya) |
| Jul 22, 2022 | 3 | Rule 7.1 Corporate Disclosure Statement (1) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Bausch Health Companies Inc. for Bausch Health Americas, Inc., Bausch Health Ireland Limited, Bausch Health US, LLC. Document filed by Bausch Health Americas, Inc., Bausch Health Ireland Limited, Bausch Health US, LLC..(Anand, Nitya) |
| Jul 22, 2022 | 4 | AO 120 Form Patent/Trademark - Notice of Submission by Attorney (1) Docket Text: AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review..(Anand, Nitya) |
| Jul 22, 2022 | 5 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceuticals Inc., re: [1] Complaint,. Document filed by Bausch Health Americas, Inc., Bausch Health Ireland Limited, Bausch Health US, LLC..(Anand, Nitya) |
| Jul 22, 2022 | 6 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceuticals U.S.A., Inc., re: [1] Complaint,. Document filed by Bausch Health Americas, Inc., Bausch Health Ireland Limited, Bausch Health US, LLC..(Anand, Nitya) |
| Jul 22, 2022 | 7 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Taro Pharmaceutical Industries Ltd., re: [1] Complaint,. Document filed by Bausch Health Americas, Inc., Bausch Health Ireland Limited, Bausch Health US, LLC..(Anand, Nitya) |
| Jul 22, 2022 | 1 | Complaint* (1) |
